Tech Company Financing Transactions
StemoniX Funding Round
StemoniX secured a $14.4 million Series B financing round on 3/1/2019. Backers included Brightstone Venture Capital, Alumni Capital Network and Crescent Ridge Partners.
Transaction Overview
Company Name
Announced On
3/1/2019
Transaction Type
Venture Equity
Amount
$14,400,000
Round
Series B
Investors
Brightstone Venture Capital (Lead Investor) (Patrick O'Shaughnessy)
Proceeds Purpose
The new financing will allow StemoniX to expand its commercial operations at its sites in Minnesota and California supporting the company's microBrain, microHeart, and Discovery as a Service offerings.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
13300 67th Ave. North
Maple Grove, MN 55311
USA
Maple Grove, MN 55311
USA
Phone
Website
Email Address
Overview
StemoniX is accelerating the discovery of new drugs by creating ready-to-use pre-clinical plates containing biologically relevant human microOrgans. Engineered from human induced pluripotent stem cells (iPSC), these microOrgan platforms enable high throughput human drug screening without the need for drugs to enter a human body.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ping Yeh
Chief Financial Officer
Dimas Jiménez
Chief Medical Officer
Murdoc Khaleghi
Co-Founder
Robert Petcavich
Browse more venture capital transactions:
Prev: 3/1/2019: Mintigo venture capital transaction
Next: 3/4/2019: KoBold Metals venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs